文献速递腹部介入CTMRUS

腹腔镜肝切除术与腹腔镜射频消融治疗3 cm以下包膜下肝细胞癌:倾向性评分匹配的治疗结局分析

Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular Carcinomas Smaller Than 3 cm: Analysis of Treatment Outcomes Using Propensity Score Matching.
PubMed 文献 · Korean J Radiol · 2022-03-08

本研究回顾性纳入2014年1月至2016年12月间接受腹腔镜肝切除术(LHR)或腹腔镜射频消融(LRFA)作为单发包膜下肝细胞癌(1-3 cm)首次治疗的患者,经两名介入放射科医生评估LRFA可行性后,最终纳入60例LHR可行患者和29例LRFA患者,行倾向性评分匹配后每组23例。匹配后两组累积局部肿瘤进展率和总生存率无显著差异(p=0.900和0.003),5年局部肿瘤进展率分别为4.6%和4.4%,总生存率分别为100%和90.7%;无复发生存率在LHR组较高但未达统计学显著(p=0.070),5年无复发生存率分别为78.3%和45.3%。多变量分析显示总生存(HR 1.33,95%CI 0.12-1.54,p=0.818)和无复发生存(HR 2.01,95%CI 0.87-4.66,p=0.102)在两组间均无显著差异。结论认为对于1-3 cm单发包膜下肝细胞癌,LHR与LRFA的治疗结局无显著差异,无复发生存差异需更大规模研究进一步评估。

要点

  • 对于1-3 cm单发包膜下肝细胞癌,LHR与LRFA的5年局部肿瘤进展率分别为4.6%和4.4%,无显著差异(p=0.900)。
  • 匹配后LRFA组5年总生存率为90.7%,LHR组为100%,但原文报告p=0.003,与「无显著差异」的表述并存,原文此处表述有矛盾。
  • 多变量分析中LRFA组较LHR组总生存HR为1.33(95%CI 0.12-1.54,p=0.818),无复发生存HR为2.01(95%CI 0.87-4.66,p=0.102),均未达统计学显著。

核心结论

  • 对于1-3 cm单发包膜下肝细胞癌,LHR与LRFA的治疗结局无显著差异;无复发生存差异需更大规模研究进一步评估。

研究设计与样本

  • 回顾性研究,筛选2014年1月至2016年12月间连续244例接受LHR或LRFA的患者,由两名介入放射科医生回顾性评估LHR患者行LRFA的可行性,最终纳入60例LHR可行患者和29例LRFA患者(共89例),行倾向性评分匹配后每组23例。

诊断标准与关键数值

  • 倾向性评分匹配后,LHR组与LRFA组5年局部肿瘤进展率分别为4.6%和4.4%(p=0.900),5年总生存率分别为100%和90.7%(原文报告p=0.003),5年无复发生存率分别为78.3%和45.3%(p=0.070)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文结论指出无复发生存差异需在更大规模研究中进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the therapeutic outcomes of laparoscopic hepatic resection (LHR) and laparoscopic radiofrequency ablation (LRFA) for single subcapsular hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: We screened 244 consecutive patients who had received either LHR or LRFA between January 2014 and December 2016. The feasibility of LRFA in patients who underwent LHR was retrospectively assessed by two interventional radiologists. Finally, 60 LRFA-feasible patients who had received LHR and 29 patients who had received LRFA as the first treatment for a solitary subcapsular HCC between 1 cm and 3 cm were finally included. We compared the therapeutic outcomes, including local tumor progression (LTP), recurrence-free survival (RFS), and overall survival (OS) between the two groups before and after propensity score (PS) matching. Multivariable Cox proportional hazard regression was also used to evaluate the difference in OS and RFS between the two groups for all 89 patients.

RESULTS: PS matching yielded 23 patients in each group. The cumulative LTP and OS rates were not significantly different between the LHR and LRFA groups after PS matching (p = 0.900 and 0.003, respectively). The 5-year LTP rates were 4.6% and 4.4%, respectively, and OS rates were 100% and 90.7%, respectively. The RFS rate was higher in LHR group without statistical significance (p = 0.070), with 5-year rates of 78.3% and 45.3%, respectively. OS was not significantly different between the LHR (reference) and LRFA groups in multivariable analyses, with a hazard ratio (HR) of 1.33 (95% confidence interval, 0.12-1.54) (p = 0.818). RFS was higher in LHR (reference) than in LRFA without statistical significance in multivariable analysis, with an HR of 2.01 (0.87-4.66) (p = 0.102).

CONCLUSION: There was no significant difference in therapeutic outcomes between LHR and LRFA for single subcapsular HCCs measuring 1-3 cm. The difference in RFS should be further evaluated in a larger study.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Ko, Lee, Ahn, et al. Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular Carcinomas Smaller Than 3 cm: Analysis of Treatment Outcomes Using Propensity Score Matching. Korean J Radiol. 2022. PMID: 35289151. doi:10.3348/kjr.2021.0786

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。